Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells <i>via</i> Inhibition of Organic Cation Transporter-Reference-Cited by-同舟云学术

Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells via Inhibition of Organic Cation Transporter

Published:2020-11-01 Issue:11 Volume:43 Page:1693-1698
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Soodvilai Sirima¹,Meetam Paranee²,Siangjong Lawan²,Chokchaisiri Ratchanaporn³,Suksamrarn Apichart⁴,Soodvilai Sunhapas⁵

Affiliation:

1. Department of Pharmaceutical Technology, College of Pharmacy, Rangsit University

2. Department of Biopharmacy, Faculty of Pharmacy, Silpakorn University

3. Department of Chemistry, School of Science, University of Phayao

4. Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Ramkhamhaeng University

5. Research Center of Transporter Protein for Medical Innovation and Department of Physiology, Faculty of Science, Mahidol University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/43/11/43_b20-00392/_pdf

Reference30 articles.

1. 1) Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer, 7, 573–584 (2007).

2. 2) Frezza M, Hindo S, Chen D, Davenport A, Schmitt S, Tomco D, Dou QP. Novel metals and metal complexes as platforms for cancer therapy. Curr. Pharm. Des., 16, 1813–1825 (2010).

3. 3) Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J. Clin. Oncol., 21, 3194–3200 (2003).

4. 4) Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N. Engl. J. Med., 357, 1705–1715 (2007).

5. 5) Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J. Clin. Oncol., 12, 701–706 (1994).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The toxicity of cisplatin derives from effects on renal organic ion transporters expression and serum endogenous substance levels;Food and Chemical Toxicology;2024-10

2. Efficient proximal tubule-on-chip model from hiPSC-derived kidney organoids for functional analysis of renal transporters;iScience;2024-09

3. Germacrone alleviates breast cancer‐associated osteolysis by inhibiting osteoclastogenesis via inhibition of MAPK/NF‐κB signaling pathways;Phytotherapy Research;2024-04

4. Evaluation of the therapeutic efficacy of Vitex agnus-castus extract on cisplatin-induced hematotoxicity in female Wistar rats;Veterinary World;2023-11

5. Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy;Frontiers in Endocrinology;2023-06-09